- Home
- TCBP vs KXIN Comparison
TCBP vs KXIN Comparison
Compare TCBP & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- KXIN
- Stock Information
- Founded
- TCBP 2013
- KXIN 2015
- Country
- TCBP United Kingdom
- KXIN China
- Employees
- TCBP N/A
- KXIN N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- TCBP Health Care
- KXIN Consumer Discretionary
- Exchange
- TCBP Nasdaq
- KXIN Nasdaq
- Market Cap
- TCBP 3.0M
- KXIN 3.0M
- IPO Year
- TCBP 2022
- KXIN N/A
- Fundamental
- Price
- TCBP $0.68
- KXIN $2.60
- Analyst Decision
- TCBP
- KXIN
- Analyst Count
- TCBP 0
- KXIN 0
- Target Price
- TCBP N/A
- KXIN N/A
- AVG Volume (30 Days)
- TCBP 3.0M
- KXIN 3.0M
- Earning Date
- TCBP 11-29-2024
- KXIN 01-01-0001
- Dividend Yield
- TCBP N/A
- KXIN N/A
- EPS Growth
- TCBP N/A
- KXIN N/A
- EPS
- TCBP N/A
- KXIN N/A
- Revenue
- TCBP N/A
- KXIN $12,679,000.00
- Revenue This Year
- TCBP N/A
- KXIN N/A
- Revenue Next Year
- TCBP N/A
- KXIN N/A
- P/E Ratio
- TCBP N/A
- KXIN N/A
- Revenue Growth
- TCBP N/A
- KXIN N/A
- 52 Week Low
- TCBP $0.56
- KXIN $2.28
- 52 Week High
- TCBP $138.00
- KXIN $148.86
- Technical
- Relative Strength Index (RSI)
- TCBP 23.01
- KXIN 38.07
- Support Level
- TCBP $1.05
- KXIN $2.80
- Resistance Level
- TCBP $1.25
- KXIN $7.30
- Average True Range (ATR)
- TCBP 0.22
- KXIN 0.86
- MACD
- TCBP 0.06
- KXIN -0.09
- Stochastic Oscillator
- TCBP 10.36
- KXIN 6.37
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.